MAYNE PHARMA GROUP LIMITED — Director's Dealing 2016

Dec 11, 2016

Appendix
3Y Change
of
Director’s
Interest
Notice

**Appendix

3Y**

Rule
3.19A.2

**Change

of
Director’s
Interest
Notice**

_Information
or
documents
not
available
now
must
be
given
to
ASX
as
soon
as
available.

Information
and documents
given
to
ASX
become
ASX’s
property
and
may
be
made
public._

Introduced

30/09/01
Amended
01/01/11

Name of entity	Mayne Pharma Group Limited
ABN	76 115 832 963

We
(the
entity)
give
ASX
the
following
information
under
listing
rule
3.19A.2
and
as
agent
for
the director
for
the
purposes
of
section
205G
of
the
Corporations
Act.

Name of Director	Bruce Mathieson
Date of last notice	7 July 2016

Part
1
-­‐
Change
of
director’s
relevant
interests
in
securities In
the
case
of
a
trust,
this
includes
interests
in
the
trust
made
available
by
the
responsible
entity
of
the
trust

Note:
In
the
case
of
a
company,
interests
which
come
within
paragraph
(i)
of
the
definition
of
“notifiable
interest
of
a
director”
should
be disclosed
in
this
part.

Direct or indirect interest	Indirect interest
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	1) Mrs Jill Mathieson 2) Investment Holdings Pty Ltd 3) BLM Superannuation Nominees Pty Ltd
Date of change	8 December 2016
No. of securities held prior to change	1,105,797 Ordinary Fully Paid Shares (1) 86,591,916 Ordinary Fully Paid Shares (2) 2,571,786 Ordinary Fully Paid Shares (3)
Class	Ordinary fully paid shares
Number acquired	200,000 Ordinary Fully Paid Shares (3)
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$290,333.14
No. of securities held after change	1,105,797 Ordinary Fully Paid Shares (1) 86,591,916 Ordinary Fully Paid Shares (2) 2,771,786 Ordinary Fully Paid Shares (3)
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestmentplan, participation in buy-back	On market trade

• See
  chapter
  19
  for
  defined
  terms.

01/01/2011
Appendix
3Y
Page
1

Appendix
3Y Change
of
Director’s
Interest
Notice

**Part

2
–
Change
of
director’s
interests
in
contracts**

Note:
In
the
case
of
a
company,
interests
which
come
within
paragraph
(ii)
of
the
definition
of
“notifiable
interest
of
a
director”
should
be disclosed
in
this
part.

Detail of contract
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change
Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period whereprior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/a
If prior written clearance was provided, on what date was this provided?	N/a

Part 3 –+Closed period
Were the interests in the securities or contracts	No
detailed above traded during a+closed period
whereprior written clearance was required?
If so, was prior written clearance provided to allow	N/a
the trade to proceed during this period?
If prior written clearance was provided, on what	N/a
date was this provided?

• See
  chapter
  19
  for
  defined
  terms.

Appendix
3Y
Page
2

01/01/2011